CC
BMEZ icon

CF Capital’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

CF Capital’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-259,913
Closed -$3.74M – 46
2024
Q4 		$3.74M Buy
+259,913
New +$4.02M 4.03% 8

Other funds holding BMEZ

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

CF Capital's BMEZ Position: Q1 2025 in Review

CF Capital sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2025, closing a stake of 259,913 shares — an estimated $3.74M sold.

CF Capital first reported a position in BMEZ in Q4 2024 and held it in 1 quarter. The position peaked at $3.74M in Q4 2024. 98 funds tracked by Wall St. Rank hold BMEZ as of Q1 2025.

  • CF Capital reported no remaining BlackRock Health Sciences Trust II position as of Q1 2025 after selling out during the quarter.
  • CF Capital sold 259,913 BlackRock Health Sciences Trust II shares in Q1 2025, an estimated $3.74M.
  • CF Capital first reported a position in BlackRock Health Sciences Trust II in Q4 2024 and held it in 1 quarter.
  • CF Capital's BlackRock Health Sciences Trust II position peaked at $3.74M in Q4 2024.
  • 98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2025.

Based on CF Capital's 13F filing for Q1 2025, filed 14 May 2025.